742 related articles for article (PubMed ID: 32766169)
1. Interactions Between Gut Microbiota, Host, and Herbal Medicines: A Review of New Insights Into the Pathogenesis and Treatment of Type 2 Diabetes.
Zheng Y; Gou X; Zhang L; Gao H; Wei Y; Yu X; Pang B; Tian J; Tong X; Li M
Front Cell Infect Microbiol; 2020; 10():360. PubMed ID: 32766169
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Molecular Mechanisms of the Interplay Between Herbal Medicines and Gut Microbiota.
Xu J; Chen HB; Li SL
Med Res Rev; 2017 Sep; 37(5):1140-1185. PubMed ID: 28052344
[TBL] [Abstract][Full Text] [Related]
3. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.
Chen Y; Wang M
Drug Des Devel Ther; 2021; 15():4849-4863. PubMed ID: 34876807
[TBL] [Abstract][Full Text] [Related]
4. Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.
Xiao S; Liu C; Chen M; Zou J; Zhang Z; Cui X; Jiang S; Shang E; Qian D; Duan J
Appl Microbiol Biotechnol; 2020 Jan; 104(1):303-317. PubMed ID: 31758238
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota: A new target for T2DM prevention and treatment.
Liu L; Zhang J; Cheng Y; Zhu M; Xiao Z; Ruan G; Wei Y
Front Endocrinol (Lausanne); 2022; 13():958218. PubMed ID: 36034447
[TBL] [Abstract][Full Text] [Related]
6. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.
Hasain Z; Mokhtar NM; Kamaruddin NA; Mohamed Ismail NA; Razalli NH; Gnanou JV; Raja Ali RA
Front Cell Infect Microbiol; 2020; 10():188. PubMed ID: 32500037
[TBL] [Abstract][Full Text] [Related]
8. Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus.
Wu J; Yang K; Fan H; Wei M; Xiong Q
Front Endocrinol (Lausanne); 2023; 14():1114424. PubMed ID: 37229456
[TBL] [Abstract][Full Text] [Related]
9. Edible traditional Chinese medicines improve type 2 diabetes by modulating gut microbiotal metabolites.
Chen S; Jiao Y; Han Y; Zhang J; Deng Y; Yu Z; Wang J; He S; Cai W; Xu J
Acta Diabetol; 2024 Apr; 61(4):393-411. PubMed ID: 38227209
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota: The Potential Key Target of TCM's Therapeutic Effect of Treating Different Diseases Using the Same Method-UC and T2DM as Examples.
Zhang B; Liu K; Yang H; Jin Z; Ding Q; Zhao L
Front Cell Infect Microbiol; 2022; 12():855075. PubMed ID: 35433500
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications.
Zhang L; Chu J; Hao W; Zhang J; Li H; Yang C; Yang J; Chen X; Wang H
Mediators Inflamm; 2021; 2021():5110276. PubMed ID: 34447287
[TBL] [Abstract][Full Text] [Related]
12. Effects of Oral Glucose-Lowering Agents on Gut Microbiota and Microbial Metabolites.
Wang D; Liu J; Zhou L; Zhang Q; Li M; Xiao X
Front Endocrinol (Lausanne); 2022; 13():905171. PubMed ID: 35909556
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota: A target for heavy metal toxicity and a probiotic protective strategy.
Duan H; Yu L; Tian F; Zhai Q; Fan L; Chen W
Sci Total Environ; 2020 Nov; 742():140429. PubMed ID: 32629250
[TBL] [Abstract][Full Text] [Related]
14. Gut-targeted therapies for type 2 diabetes mellitus: A review.
Xu TC; Liu Y; Yu Z; Xu B
World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
Zhou Z; Sun B; Yu D; Zhu C
Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
[TBL] [Abstract][Full Text] [Related]
16. The interplay between herbal medicines and gut microbiota in metabolic diseases.
Wang L; Gou X; Ding Y; Liu J; Wang Y; Wang Y; Zhang J; Du L; Peng W; Fan G
Front Pharmacol; 2023; 14():1105405. PubMed ID: 37033634
[TBL] [Abstract][Full Text] [Related]
17. Role of the gut microbiota in type 2 diabetes and related diseases.
Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
[TBL] [Abstract][Full Text] [Related]
18. Exercise for the Diabetic Gut-Potential Health Effects and Underlying Mechanisms.
Valder S; Brinkmann C
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215463
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
[TBL] [Abstract][Full Text] [Related]
20. Alleviation Effects of GQD, a Traditional Chinese Medicine Formula, on Diabetes Rats Linked to Modulation of the Gut Microbiome.
Tian J; Bai B; Gao Z; Yang Y; Wu H; Wang X; Wang J; Li M; Tong X
Front Cell Infect Microbiol; 2021; 11():740236. PubMed ID: 34692563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
